US Stock MarketDetailed Quotes

Supernus Pharmaceuticals (SUPN)

Watchlist
  • 51.360
  • +0.830+1.64%
Close May 13 16:00 ET
  • 51.360
  • 0.0000.00%
Post 16:53 ET
2.98BMarket Cap-100.71P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Supernus Pharmaceuticals (SUPN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
38.63%207.71M
8.63%718.95M
21.48%211.57M
9.34%192.1M
-1.71%165.45M
4.30%149.82M
8.94%661.82M
5.99%174.16M
14.17%175.69M
24.17%168.33M
Operating revenue
38.63%207.71M
8.63%718.95M
21.48%211.57M
9.34%192.1M
-1.71%165.45M
4.30%149.82M
8.94%661.82M
5.99%174.16M
14.17%175.69M
24.17%168.33M
Cost of revenue
48.39%23.39M
-4.29%74.56M
-11.84%23.01M
7.86%18.97M
-6.08%16.83M
-3.35%15.76M
-7.01%77.91M
32.97%26.1M
-10.30%17.58M
-15.05%17.92M
Gross profit
37.49%184.31M
10.36%644.39M
27.36%188.57M
9.51%173.14M
-1.19%148.63M
5.28%134.06M
11.49%583.91M
2.33%148.06M
17.74%158.11M
31.39%150.41M
Operating expense
39.22%190.26M
34.01%681.25M
38.36%174.74M
97.31%233.37M
3.25%136.49M
3.86%136.66M
-0.39%508.36M
0.48%126.3M
-6.57%118.28M
0.71%132.2M
Selling and administrative expenses
39.17%125.17M
50.99%485.56M
54.13%122.39M
157.59%179.68M
8.90%93.55M
3.96%89.94M
-4.39%321.58M
-2.30%79.41M
-15.66%69.75M
-1.01%85.9M
-Selling and marketing expense
37.45%86.98M
27.00%288.65M
52.37%83.19M
41.84%77.06M
10.76%65.13M
6.23%63.28M
-0.83%227.29M
-1.24%54.59M
-4.33%54.33M
-1.82%58.8M
-General and administrative expense
43.25%38.2M
108.84%196.91M
57.98%39.21M
565.33%102.62M
4.87%28.42M
-1.05%26.67M
-12.02%94.29M
-4.57%24.82M
-40.48%15.42M
0.79%27.1M
Research and development costs
46.46%39.44M
-2.35%106.24M
-2.86%27.83M
1.14%29.37M
-15.54%22.12M
8.01%26.93M
18.78%108.8M
22.70%28.65M
28.17%29.04M
7.40%26.18M
Depreciation amortization depletion
29.61%25.64M
14.72%89.46M
34.43%24.53M
24.82%24.33M
3.54%20.82M
-1.74%19.79M
-5.35%77.98M
-13.41%18.24M
-8.26%19.49M
0.00%20.11M
-Depreciation and amortization
29.61%25.64M
14.72%89.46M
34.43%24.53M
24.82%24.33M
3.54%20.82M
-1.74%19.79M
-5.35%77.98M
-13.41%18.24M
-8.26%19.49M
0.00%20.11M
Operating profit
-128.85%-5.94M
-148.79%-36.86M
-36.48%13.82M
-251.22%-60.23M
-33.34%12.14M
38.89%-2.6M
463.72%75.56M
14.60%21.76M
418.47%39.83M
208.44%18.21M
Net non-operating interest income expense
-46.17%2.38M
-18.21%13.25M
-59.35%2.02M
-44.44%2.28M
21.30%4.53M
30.30%4.43M
101.59%16.2M
150.60%4.98M
134.04%4.1M
711.52%3.73M
Non-operating interest income
-46.17%2.38M
-18.21%13.25M
-59.35%2.02M
-44.44%2.28M
21.30%4.53M
30.30%4.43M
55.02%16.2M
150.60%4.98M
134.04%4.1M
172.48%3.73M
Non-operating interest expense
----
--0
----
----
----
----
--0
--0
--0
--0
Other net income (expense)
68.79%-2.39M
-516.02%-25.42M
-4,888.48%-17.76M
-799.54%-7.66M
132.72%6.11M
98.22%-356K
122.81%1.02M
651.27%4.36M
Special income (charges)
68.79%-2.39M
-516.02%-25.42M
-4,888.48%-17.76M
--0
--0
-799.54%-7.66M
132.72%6.11M
98.22%-356K
122.81%1.02M
651.27%4.36M
-Less：Restructuring and merger&acquisition
-68.79%2.39M
516.02%25.42M
4,888.48%17.76M
--0
--0
799.54%7.66M
-302.77%-6.11M
274.51%356K
-122.81%-1.02M
-651.27%-4.36M
-Less:Impairment of capital assets
----
--0
----
----
----
----
--0
----
----
----
Income before tax
-2.04%-5.95M
-150.10%-49.03M
-107.25%-1.91M
-228.95%-57.95M
-36.62%16.67M
-2,499.59%-5.83M
3,434.49%97.87M
2,564.85%26.38M
354.47%44.94M
253.57%26.3M
Income tax
-160.99%-3.66M
-143.66%-10.48M
-80.18%2.19M
-299.15%-12.84M
-191.29%-5.83M
4,938.66%6M
1,552.10%24.01M
6,075.14%11.05M
-75.08%6.45M
139.19%6.39M
Net income
80.61%-2.29M
-152.19%-38.55M
-126.78%-4.11M
-217.20%-45.12M
12.97%22.5M
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
Net income continuous Operations
80.61%-2.29M
-152.19%-38.55M
-126.78%-4.11M
-217.20%-45.12M
12.97%22.5M
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
Minority interest income
Net income attributable to the parent company
80.61%-2.29M
-152.19%-38.55M
-126.78%-4.11M
-217.20%-45.12M
12.97%22.5M
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
80.61%-2.29M
-152.19%-38.55M
-126.78%-4.11M
-217.20%-45.12M
12.97%22.5M
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
Basic earnings per share
80.95%-0.04
-150.75%-0.68
-125.00%-0.07
-214.29%-0.8
11.11%0.4
-0.21
6,600.00%1.34
1,507.99%0.28
341.38%0.7
1,900.00%0.36
Diluted earnings per share
80.95%-0.04
-151.52%-0.68
-125.93%-0.07
-215.94%-0.8
11.11%0.4
-0.21
6,500.00%1.32
1,450.57%0.27
337.93%0.69
1,900.00%0.36
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 38.63%207.71M8.63%718.95M21.48%211.57M9.34%192.1M-1.71%165.45M4.30%149.82M8.94%661.82M5.99%174.16M14.17%175.69M24.17%168.33M
Operating revenue 38.63%207.71M8.63%718.95M21.48%211.57M9.34%192.1M-1.71%165.45M4.30%149.82M8.94%661.82M5.99%174.16M14.17%175.69M24.17%168.33M
Cost of revenue 48.39%23.39M-4.29%74.56M-11.84%23.01M7.86%18.97M-6.08%16.83M-3.35%15.76M-7.01%77.91M32.97%26.1M-10.30%17.58M-15.05%17.92M
Gross profit 37.49%184.31M10.36%644.39M27.36%188.57M9.51%173.14M-1.19%148.63M5.28%134.06M11.49%583.91M2.33%148.06M17.74%158.11M31.39%150.41M
Operating expense 39.22%190.26M34.01%681.25M38.36%174.74M97.31%233.37M3.25%136.49M3.86%136.66M-0.39%508.36M0.48%126.3M-6.57%118.28M0.71%132.2M
Selling and administrative expenses 39.17%125.17M50.99%485.56M54.13%122.39M157.59%179.68M8.90%93.55M3.96%89.94M-4.39%321.58M-2.30%79.41M-15.66%69.75M-1.01%85.9M
-Selling and marketing expense 37.45%86.98M27.00%288.65M52.37%83.19M41.84%77.06M10.76%65.13M6.23%63.28M-0.83%227.29M-1.24%54.59M-4.33%54.33M-1.82%58.8M
-General and administrative expense 43.25%38.2M108.84%196.91M57.98%39.21M565.33%102.62M4.87%28.42M-1.05%26.67M-12.02%94.29M-4.57%24.82M-40.48%15.42M0.79%27.1M
Research and development costs 46.46%39.44M-2.35%106.24M-2.86%27.83M1.14%29.37M-15.54%22.12M8.01%26.93M18.78%108.8M22.70%28.65M28.17%29.04M7.40%26.18M
Depreciation amortization depletion 29.61%25.64M14.72%89.46M34.43%24.53M24.82%24.33M3.54%20.82M-1.74%19.79M-5.35%77.98M-13.41%18.24M-8.26%19.49M0.00%20.11M
-Depreciation and amortization 29.61%25.64M14.72%89.46M34.43%24.53M24.82%24.33M3.54%20.82M-1.74%19.79M-5.35%77.98M-13.41%18.24M-8.26%19.49M0.00%20.11M
Operating profit -128.85%-5.94M-148.79%-36.86M-36.48%13.82M-251.22%-60.23M-33.34%12.14M38.89%-2.6M463.72%75.56M14.60%21.76M418.47%39.83M208.44%18.21M
Net non-operating interest income expense -46.17%2.38M-18.21%13.25M-59.35%2.02M-44.44%2.28M21.30%4.53M30.30%4.43M101.59%16.2M150.60%4.98M134.04%4.1M711.52%3.73M
Non-operating interest income -46.17%2.38M-18.21%13.25M-59.35%2.02M-44.44%2.28M21.30%4.53M30.30%4.43M55.02%16.2M150.60%4.98M134.04%4.1M172.48%3.73M
Non-operating interest expense ------0------------------0--0--0--0
Other net income (expense) 68.79%-2.39M-516.02%-25.42M-4,888.48%-17.76M-799.54%-7.66M132.72%6.11M98.22%-356K122.81%1.02M651.27%4.36M
Special income (charges) 68.79%-2.39M-516.02%-25.42M-4,888.48%-17.76M--0--0-799.54%-7.66M132.72%6.11M98.22%-356K122.81%1.02M651.27%4.36M
-Less：Restructuring and merger&acquisition -68.79%2.39M516.02%25.42M4,888.48%17.76M--0--0799.54%7.66M-302.77%-6.11M274.51%356K-122.81%-1.02M-651.27%-4.36M
-Less:Impairment of capital assets ------0------------------0------------
Income before tax -2.04%-5.95M-150.10%-49.03M-107.25%-1.91M-228.95%-57.95M-36.62%16.67M-2,499.59%-5.83M3,434.49%97.87M2,564.85%26.38M354.47%44.94M253.57%26.3M
Income tax -160.99%-3.66M-143.66%-10.48M-80.18%2.19M-299.15%-12.84M-191.29%-5.83M4,938.66%6M1,552.10%24.01M6,075.14%11.05M-75.08%6.45M139.19%6.39M
Net income 80.61%-2.29M-152.19%-38.55M-126.78%-4.11M-217.20%-45.12M12.97%22.5M-9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M
Net income continuous Operations 80.61%-2.29M-152.19%-38.55M-126.78%-4.11M-217.20%-45.12M12.97%22.5M-9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M
Minority interest income
Net income attributable to the parent company 80.61%-2.29M-152.19%-38.55M-126.78%-4.11M-217.20%-45.12M12.97%22.5M-9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 80.61%-2.29M-152.19%-38.55M-126.78%-4.11M-217.20%-45.12M12.97%22.5M-9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M
Basic earnings per share 80.95%-0.04-150.75%-0.68-125.00%-0.07-214.29%-0.811.11%0.4-0.216,600.00%1.341,507.99%0.28341.38%0.71,900.00%0.36
Diluted earnings per share 80.95%-0.04-151.52%-0.68-125.93%-0.07-215.94%-0.811.11%0.4-0.216,500.00%1.321,450.57%0.27337.93%0.691,900.00%0.36
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -